Stock ZYUS ZYUS LIFE SCIENCES CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Consensus ZYUS Life Sciences Corporation

Equities

ZYUS

CA9899601095

Market Closed - Toronto S.E.
Other stock markets
 03:11:34 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.05 CAD +3.96% Intraday chart for ZYUS Life Sciences Corporation +5.00% +16.67%
Apr. 23 ZYUS Life Sciences Receives US Patent for Pain Management Drug Candidate MT
Mar. 05 Calian Group and MDA Brief: Calian Says "Strengthens Nuclear Capability" with Acquisition of MDA Ltd. Nuclear Assets MT

Evolution of the average Target Price on ZYUS Life Sciences Corporation

Price target over the last 5 years

History of analyst recommendation changes

ff2c60e172da8b45.j5FXAADuV3ZKLl7ucU3olQLL_ZgFle764wRTQwC0U-Y.1ssfWUuBZDckfSetFTzc51G4kdZw4KiLhFUwCU3hBbnq3BFVarZgMwRrGw~29de0146c1d0c6d22dc92fbb0f908cb2

Analyst Recommendations on ZYUS Life Sciences Corporation

ZYUS Life Sciences Initiated at Speculative Buy at Stifel GMP; Price Target Set at C$4.00 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
1.05 CAD
Average target price
2.75 CAD
Spread / Average Target
+161.90%
High Price Target
4 CAD
Spread / Highest target
+280.95%
Low Price Target
1.5 CAD
Spread / Lowest Target
+42.86%

Consensus detail

Consensus revision (last 18 months)

Analysts covering ZYUS Life Sciences Corporation

Stifel GMP

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ZYUS Stock
  4. Consensus ZYUS Life Sciences Corporation